Interestingly, KLF4 and other stemness genes (Oct4, Sox2 and c‐Myc) have proposed as putative targets for HCC therapy because they contributed for maintaining cancer stem cells (CSCs), having strong chemoresistance.45, 47, 48. The gene discussed is POU5F1; the disease is hepatocellular carcinoma.